OP2LYSIS DEVELOPMENT
Open bankruptcySummary
A bankruptcy procedure is open for OP2LYSIS DEVELOPMENT according to publications in the Belgian State Gazette. The 2024 annual accounts show equity of €1.82M and a net result of €-116k.
Signals
Four signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Persistent losses
Two consecutive loss-making years (2023 and 2024); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2024Net result per financial year
222324
2022 to 2024 · latest year €-116k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 18-06-2025, 43 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
not confirmed
2024
43 d early
2023
48 d early
2022
3 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-116k▲ 47.2%
2023 · €-220k
Working capital
€-298k
2023 · €520k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line202220232024
Operating result€-177k-€-250k▼ 41.1%€-96k▲ 61.4%
Net result€-146k-€-220k▼ 50.5%€-116k▲ 47.2%
Equity€1.44M-€1.86M▲ 29.4%€1.82M▼ 2.0%
Total assets€2.91M-€3.17M▲ 9.0%€3.03M▼ 4.4%
Debt€1.47M-€1.31M▼ 10.9%€1.21M▼ 7.8%
Working capital€1.08M-€520k▼ 51.9%€-298k
Staff (FTE)1.7-1.9▲ 11.8%1▼ 47.4%
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €96k in 2024 against €250k in 2023; the loss shrinks.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €3.03M
Fixed assets
€2.87M ▲ 15.5%
Current assets
€163k ▼ 76.3%
Equity and liabilities €3.03M
Equity
€1.82M ▼ 2.0%
Debt
€1.21M ▼ 7.8%
Debt's share of the balance-sheet total falls from 41.4% to 39.9%. Equity and debt are lower.
Key figures and ratios
Current ratio
0.35▼
2023 · 4.09
Debt to equity
0.66▼
2023 · 0.71
ROE
-6.4%▲
2023 · -11.8%
ROA
-3.8%▲
2023 · -6.9%
Debt ≤ 1 year
€461k▲
2023 · €168k
Debt > 1 year
€748k▼
2023 · €1.14M
Income taxes
€-15k▲
2023 · €-51k
Staff costs
€74k▼
2023 · €221k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|
| Remuneration, social security and pensions62 | €264k | €221k | €74k | ▼ 66.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1k | €0 | - | - |
| Other operating charges640/8 | €695 | €418 | €2k | ▲ 315% |
| Gross operating margin9900 | €89k | €-29k | €-20k | ▲ 29.4% |
| Operating profit (loss)9901 | €-177k | €-250k | €-96k | ▲ 61.4% |
| Financial income75/76B | €1 | €747 | €2k | ▲ 177% |
| Recurring financial income75 | €1 | €747 | €2k | ▲ 177% |
| Financial charges65/66B | €19k | €22k | €36k | ▲ 67.5% |
| Recurring financial charges65 | €19k | €22k | €36k | ▲ 67.5% |
| Profit (loss) for the period before taxes9903 | €-196k | €-271k | €-131k | ▲ 51.7% |
| Income taxes67/77 | €-50k | €-51k | €-15k | ▲ 71.3% |
| Profit (loss) for the period9904 | €-146k | €-220k | €-116k | ▲ 47.2% |
| Profit (loss) for the period to be appropriated9905 | €-146k | €-220k | €-116k | ▲ 47.2% |
| Line | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €2.91M | €3.17M | €3.03M | ▼ 4.4% |
| Fixed assets21/28 | €1.48M | €2.48M | €2.87M | ▲ 15.5% |
| Intangible fixed assets21 | €1.48M | €2.48M | €2.86M | ▲ 15.5% |
| Financial fixed assets28 | - | €5k | €5k | = |
| Current assets29/58 | €1.43M | €688k | €163k | ▼ 76.3% |
| Amounts receivable within one year40/41 | €1.29M | €129k | €122k | ▼ 5.9% |
| Trade receivables40 | €14k | €0 | €1k | - |
| Other amounts receivable41 | €1.28M | €129k | €121k | ▼ 6.7% |
| Cash at bank and in hand54/58 | €137k | €559k | €41k | ▼ 92.6% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €2.91M | €3.17M | €3.03M | ▼ 4.4% |
| Equity10/15 | €1.44M | €1.86M | €1.82M | ▼ 2.0% |
| Contributions10/11 | €1.06M | €1.46M | €1.46M | = |
| Capital10 | €1.06M | €1.46M | €1.46M | = |
| Issued capital100 | €1.06M | €1.46M | €1.46M | = |
| Profit (loss) carried forward14 | €-146k | €-366k | €-482k | ▼ 31.7% |
| Investment grants15 | €522k | €765k | €843k | ▲ 10.2% |
| Amounts payable17/49 | €1.47M | €1.31M | €1.21M | ▼ 7.8% |
| Amounts payable after more than one year17 | €1.13M | €1.14M | €748k | ▼ 34.6% |
| Financial debts170/4 | €1.13M | €1.14M | €748k | ▼ 34.6% |
| Amounts payable within one year42/48 | €345k | €168k | €461k | ▲ 174% |
| Financial debts43 | €175k | €0 | €251k | - |
| Credit institutions430/8 | €175k | €0 | €251k | - |
| Trade debts44 | €123k | €77k | €18k | ▼ 77.0% |
| Suppliers440/4 | €123k | €77k | €18k | ▼ 77.0% |
| Taxes, remuneration and social security45 | €29k | €10k | €1k | ▼ 89.3% |
| Taxes450/3 | €390 | €536 | €936 | ▲ 74.8% |
| Remuneration and social security454/9 | €28k | €9k | €93 | ▼ 99.0% |
| Other amounts payable47/48 | €18k | €81k | €191k | ▲ 135% |
| Accrued charges and deferred income492/3 | €957 | €0 | - | - |
| Line | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | €-146k | €-220k | €-116k | ▲ 47.2% |
| + Depreciation and write-downs630 | €1k | €0 | - | - |
| Operating cash flow (approximation) | €-145k | €-220k | €-116k | ▲ 47.2% |
| Investment in fixed assets (approximation) | - | €-1.00M | €-384k | ▲ 61.6% |
| Change in cash | - | €422k | €-517k | ▼ 223% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
13-11
Bankruptcy
Opening
Tribunal de l’entreprise de Liège, division Liège · event 27-10-2025
18-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
13-06
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial
Weakest financial yearnet €-220k
Net result drops to €-220k, the lowest in the series.
28-07
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
SignalFinancial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Liège · 1 establishment unit since 2021
Ground area
2.7 ha
Building footprint
1,406 m²
Volume, LiDAR
12,425 m³
2 parcels, Wallonia · tallest building 12.8 m, ±3 floors. Linked by address, not a title deed.
43
companies at this address
See who is registered here
1 establishment unit
OP2LYSIS DEVELOPMENT
since 20212.319.639.390
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62042B0366/00B003 | Wallonia | 1.9 ha | - | - |
| 62064A0220/00G000 | Wallonia | 8,511 m² | 1 · 1,406 m² | 12.8 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Insolvency mandates
2 mandates| Role | Name | Tenure |
|---|---|---|
| Curator | LAURENT STAS DE RICHELLE RUE CONSTANTIN
DE GERLACHE 41, 4000 LIEGE 1 |
27-10-2025 → present |
| Curator | CATHERINE
DELBOUILLE AVENUE CONSTANTIN DE GERLACHE 41,
4000 LIEGE 1 |
27-10-2025 → present |
Public money · subsidies and aid
European research
1 projectProgrammes
Horizon Europe
Projects
To deliver the first medical treatment dedicated to patients with haemorrhagic stroke
Similar companies · same sector, comparable size
SECOYA Technologies
BE 0733.945.847
Ottignies-Louvain-la-Neuve · Eq €1,842,673
DR. JOHAN VANDEN BROUCKE
BE 0479.040.735
Ieper · Eq €1,775,708
CM4Cure
BE 0765.658.810
Liège · Eq €1,771,654
Wishbone
BE 0543.516.635
Flémalle · Eq €1,766,378
NANOCYL
BE 0476.998.785
Sambreville · Eq €1,892,398
Of 762 companies in sector 72101 we hold annual accounts for 482. 268 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded17-06-2021
Fiscal year end31-12
Activities, NACEBEL 2025
72101Research and development on biotechnology
Scores and ratios are computed by Checked and are not a credit decision.